Looks like Bapineuzumab study is still going on in Europe. I don't know if Bapineuzumab is dead or not. Maybe that it or any other AZ drug needs to be given much earlier? Final verdict is not out yet IMO.
Pfizer is buying time for their test result coming?? If the tests turnout positive??? what you think they will pay for ILNS? 1-2 $ BILLION for an effective drug in a $600 billion/year market?